Cita APA (7a ed.)

B, L., YC, K., MR, S., ATH, W., & HS, H. (2021). In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. Dove Medical Press.

Cita Chicago Style (17a ed.)

B, Lawal, Kuo YC, Sumitra MR, Wu ATH, y Huang HS. In Vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. Dove Medical Press, 2021.

Cita MLA (8a ed.)

B, Lawal, et al. In Vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. Dove Medical Press, 2021.